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Abstract: Vitamin C (vitC) deficiency is associated with increased cardiovascular disease risk, but its
specific interplay with arteriolar function is unclear. This study investigates the effect of vitC
deficiency in guinea pigs on plasma biopterin status and the vasomotor responses in coronary
arteries exposed to vasoconstrictor/-dilator agents. Dunkin Hartley female guinea pigs (n = 32)
were randomized to high (1500 mg/kg diet) or low (0 to 50 mg/kg diet) vitC for 10–12 weeks.
At euthanasia, coronary artery segments were dissected and mounted in a wire-myograph. Vasomotor
responses to potassium, carbachol, sodium nitroprusside (SNP), U46619, sarafotoxin 6c (S6c) and
endothelin-1 (ET-1) were recorded. Plasma vitC and tetrahydrobiopterin were measured by HPLC.
Plasma vitC status reflected the diets with deficient animals displaying reduced tetrahydrobiopterin.
Vasoconstrictor responses to carbachol were significantly decreased in vitC deficient coronary
arteries independent of their general vasoconstrictor/vasodilator capacity (p < 0.001). Moreover,
in vitC deficient animals, carbachol-induced vasodilator responses correlated with coronary artery
diameter (p < 0.001). Inhibition of cyclooxygenases with indomethacin increased carbachol-induced
vasoconstriction, suggesting an augmented carbachol-induced release of vasodilator prostanoids.
Atropine abolished carbachol-induced vasomotion, supporting a specific muscarinic receptor effect.
Arterial responses to SNP, potassium, S6c, U46619 and ET-1 were unaffected by vitC status. The study
shows that vitC deficiency decreases tetrahydrobiopterin concentrations and muscarinic receptor
mediated contraction in coronary arteries. This attenuated vasoconstrictor response may be linked
to altered production of vasoactive arachidonic acid metabolites and reduced muscarinic receptor
expression/signaling.
Keywords: Vitamin C; ascorbic acid; vascular responses; biopterins
1. Introduction
The association between vitamin C (vitC) deficiency and an increased risk of cardiovascular
disease (CVD) in humans is well-established [1–6], though a mechanistic link is yet to be elucidated.
VitC is an essential nutrient for humans and an estimated 10–15% of adults in the Western populations
suffer from hypovitaminosis C (plasma concentration <23 µM) [7]. Pathologies of vascular diseases
are characterized by changed vasomotion as a consequence of an imbalance in vasodilation and
vasoconstriction, leading to abnormal blood flow regulation and organ dysfunction. In the vasculature,
vitC is a key component in maintaining collagen integrity of blood vessels; prolonged severe deficiency
ultimately leads to the development of bleedings and haematoma hallmarking scurvy. However, little
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is known about how non-scorbutic vitC deficiency affects the function of the vascular cells and the
vasomotion of arterioles proximal to the capillaries.
In human endothelial cells in vitro, vitC has been shown to act as specific redox modulator in
the nitric oxide (NO) synthesis essential for vasodilation [8]. Furthermore, vitC provides reducing
equivalents in the conversion of dihydrobiopterin (BH2) to tetrahydrobiopterin (BH4) [9,10], which in
turn acts as co-factor for endothelial nitric oxide syntase (eNOS) to ensure the generation of NO [11].
Reduced BH4 levels lead to eNOS uncoupling, and generation of superoxide rather than NO [12], likely
to form the strong oxidant peroxynitrite and decreasing NO bioavailability [9]. We have previously
shown that vitC deficiency in guinea pigs leads to decreased BH4 plasma concentration in vivo [13],
potentially weakening the vasodilator capacity.
Another important aspect of vitC is its antioxidant function, serving as a scavenger of reactive
oxygen species (ROS) [14]. ROS play key roles in signal transduction related to both vasodilation
and vasoconstiction [15] and can inhibit the two major endothelium-derived relaxing factors, NO and
prostacyclin [15]. While eNOS uncoupling reduces NO bioavailability, peroxynitrite can inactivate
prostacyclin synthase by tyrosin nitration of its active site [16,17]. Thus, as the primary vascular
antioxidant, vitC protects the endothelium from oxidative stress [18].
A third mechanism of vitC-associated action could be on the cholinergic response of vascular
smooth muscle cells (VSMCs). Increased oxidative stress has been found to reduce muscarinic receptor
function in smooth muscle cells of the urinary bladder [19], and studies have shown an attenuated
parasympathetic response [20] and muscarinic-cholinergic receptor density [21] in submandibular
gland acinar cells in vitC deficient guinea pigs. As coronary arteries express muscarinic receptors in
the endothelium and VSMCs, and an extensive network of cholinergic perivascular nerve fibres in the
coronary artery tree is present in guinea pigs [22], the acetylcholine analogue carbachol was applied to
study both vasodilator and vasoconstrictor responses.
In contrast to rats and mice, guinea pigs and humans share a requirement for dietary vitC. This
makes the guinea pig an excellent in vivo model for studying effects of diet-imposed vitC deficiency.
In this study, we examined a causal relationship between chronic vitC deficiency and plasma biopterin
redox status, and putative consequences on the vasodilator and vasoconstrictor responses in isolated
coronary arteries.
2. Materials and Methods
2.1. Animal Study
All experimental animal procedures were performed following protocols approved by the Danish
Animal Experimental Inspectorate under the Ministry of Environment and Food of Denmark (No.
2012-15-2934-00205). Group sizes were determined by power analysis of sample size, applying a power
of 80% and a 5% significance level. A difference of 30% was considered biologically relevant and
variations of the chosen end-points were based on our previous experience with the model [23,24].
Animals were selected by randomization from a larger, extensive, study of diet imposed vitC deficiency
in guinea pigs intended to investigate vitC transport to the brain (unpublished results). Thus, the
current data-set depicts findings from a randomly defined subset of animals, representing high vitC
intake (control) and low (deficient), thereby, reflecting the extremes of the imposed interventions of the
main study.
Seven-day old, Dunkin Hartley female guinea pigs (Envigo, Horst, The Netherlands) were
equipped with subcutaneous microchip implant for identification (Uno Pico Transponder, Zevenaar,
The Netherlands) upon arrival to the facility. Animals were randomized into weight stratified groups
and subjected to either high (n = 16; 1500 mg vitC/kg feed; Controls) or low vitC (n = 16, 0 mg vitC/kg
feed for 3 weeks, followed by 50 mg vitC/kg feed until study termination; Deficient). All diets were
chow based standard guinea pig diets for growing animals (Ssniff Spezialdiäten, Soesst, Germany),
differing only in vitC levels as confirmed by post production analysis. Animals were group-housed
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in identical floor pens and allowed free access to feed, dried hay (devoid of vitC by analysis) and
drinking water. Body-weight was monitored throughout the study period, and though vitC deficient
animals experienced a brief period (1–3 days) of weight stagnation immediately prior to changing
from 0 mg to 50 mg vitC/kg feed, clinical signs of vitC deficiency were absent and body weight was
comparable between groups at the time of euthanasia, 10–12 weeks after study start.
2.2. Euthanasia
Guinea pigs were sedated with Torbugesic Vet (2 mL/kg) (Butorphanol 10 mg/mL; ScanVet
Animal Health, Fredernsborg, Denmark) and anesthetized with 5% isofluorane (Isoba Vet 100%,
Intervet International, Boxmeer, The Netherlands) in oxygen (Conoxia® 100%, AGA A/S, Copenhagen,
Denmark) until cessation of voluntary reflexes. Blood was collected by cardiac puncture through the
apex using a 18 G needle fitted onto a 1 mL syringe previously flushed with 15% tripotassium EDTA.
Immediately hereafter, the guinea pig was euthanized by decapitation.
2.3. Wire Myography and Tissue Preparation
Immediately following euthanasia, the heart was isolated and placed into cold physiological
buffer (in mM: 117.8 NaCl, 4.0 KCl, 2.0 CaCl2, 0.9 MgCl2, 1.25 NaH2PO4, 20 NaHCO3, and 5.0 glucose).
The left anterior descending (LAD) coronary artery was dissected from surrounding myocardial tissue,
cut into 2 mm segments and directly mounted in a wire myograph (Danish Myo Technology, Aarhus,
Denmark). The anatomical localization of the LAD coronary artery is illustrated in Supplemental
Figure S1. Wire myography experiments were initiated by normalisation to an internal circumference
corresponding to 0.9 of the circumference at 13.3 kPa. Following a 15 min equilibration period in
physiological buffer the artery segments were contracted 2–3 times using 60 mM potassium (similar
composition as the above physiological buffer, except that NaCl was exchanged with KCl on equimolar
basis) to measure the vasoconstrictor reactivity of the arteries. Only segments with potassium induced
contraction >0.5 mN/mm were included in the study. After washing to obtain baseline relaxation,
the ETB receptor agonist, Sarafotoxin 6c (S6c) was added in a cumulative fashion (10−12 to 10−7 M).
Carbachol induced vasodilation and vasoconstriction (10−12 to 3 × 10−4 M) was tested following
pre-constriction with potassium (40 mM). In order to elucidate the carbachol vasomotor responses,
carbachol concentration-response curves were acquired either in absence (controls) or in presence of
the muscarinic receptor antagonist, atropine (10−5 M), the COX-inhibitor indomethacin (10−4 M) or
the eNOS inhibitor L-NAME (10−5 M). Endothelium-independent vasodilation was tested by sodium
nitroprusside (10−9 to 10−5 M) following pre-constriction with 40 mM potassium. U46619 (10−12
to 10−5 M) and endothelin-1 (ET-1)-induced (10−12 to 10−7 M) vasoconstriction were tested using
cumulative additions.
2.4. Biochemical Analysis
EDTA-stabilized blood samples were centrifuged (16,000× g, 1 min, 4 ◦C). Plasma for ascorbate
and dehydroascorbic acid (DHA) analysis was stabilized with meta-phosphoric acid prior to storage at
−80 ◦C. Previous studies have shown that both ascorbate and DHA are stable under these conditions
for at least five years [23]. Concentrations were measured by HPLC with colorimetric detection as
previously described [25,26]. The remaining plasma aliquots were stored neat at −80 ◦C until further
analysis, except for samples for BH2 and BH4 determination, where the blood was stabilized in 0.1%
dithioerythritol prior to centrifugation (2000× g, 4 min, 4 ◦C), yielding a plasma fraction, which was
analyzed by HPLC, as previously described [13].
2.5. Data and Statistical Analysis
Force data (mN) were transformed to tension (Nm−1) by dividing by twice the artery segment
length and subtracting the baseline tension values [24]. Active tension was calculated by subtracting the
passive tension from the potassium-induced active tension. Agonist-induced tension was normalized
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to the potassium induced active tension. Carachol-induced relaxation was calculated by subtracting the
active tensions from the potassium-induced (40 mM) active tension. All statistical analysis and graphs
were performed in GraphPad Prism 7.00 (GraphPad Software, La Jolla, CA, USA). Differences between
two groups were evaluated by a two-sided Student’s t-test. For multiple comparisons (in functional
myography data), two-way ANOVA repeated-measures with Sidak’s multiple comparisons was
applied. Correlations between specific outcomes were evaluated by Pearson correlation (r) coefficient
with two-tailed p-values.
2.6. Materials
Endothelin-1, human, porcine (Catalogue No. SC324, PolyPeptide Group, Strassbourg, France),
Sarafotoxin S6c (SC457, PolyPeptide Group, Strassbourg, France), 9,11-dideoxy-11α,9α-epoxy-
methanoprostaglandin F2α (BML-PG023-0001, Enzo Life Sciences, Exeter, UK). Carbamoylcholine
chloride (C4382-1G SIGMA, Sigma-Aldrich, St. Louis, MO, USA), indomethacin (I7378-5G SIGMA,
Sigma-Aldrich, St. Louis, MO, USA), Nω-nitro-L-arginine methylester hydrochloride (N5751 Sigma,
Sigma-Aldrich, St. Louis, MO, USA), atropine (A0132 SIGMA, Sigma-Aldrich, St. Louis, MO, USA),
meta-phosphoric acid (239275, Sigma, Sigma-Aldrich, St. Louis, MO, USA), 1,4-dithioerythritol (D9680,
Sigma, Sigma-Aldrich, St. Louis, MO, USA).
3. Results
3.1. Effects of Vitamin C Deficiency on Weight Gain of Animals, Plasma Ascorbate Concentration and Plasma
BH4 Concentration
Plasma vitC concentrations were measured at euthanasia, following 11 weeks on the experimental
diets. The dietary regimen was reflected in plasma ascorbate and DHA concentrations, with marked
(p < 0.001) reduction in plasma ascorbate concentration in the deficient group compared to the control
group (Table 1). VitC deficiency also led to a significant reduction in plasma BH4 concentration
(p < 0.0001) (Figure 1).
Table 1. Animal weight and plasma analyses. Data are expressed as means ± SEM, N is number of
animals, **** Different from controls, p < 0.0001, unpaired t-test.
N Controls N VitC Deficient
Weight (g) 16 625 ± 14 16 602 ± 16
Ascorbate concentration, (µM) 16 60.2 ± 5.1 16 2.3 ± 0.1 ****
Ascorbate total, (µM) 16 61.5 ± 5.3 16 2.3 ± 0.1 ****
% DHA 16 1.9 ± 0.5 16 2.2 ± 1.0
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3.2. Contractile Reactivity
The potency and efficacy of ET-1 was significantly higher than that of U46619 (p < 0.05), and
the selective ETB receptor agonist, S6c, induced only a negligible contraction in the coronary artery
segments (Table 2). VitC status did not have a significant effect on the potassium, ET-1, U46619 or S6c
vasoconstrictor responses (Figure 2a,b). In contrast to the other vasoconstrictors, potassium induced a
long-lasting vasocontractile response persisting for at least 10 min and potassium was therefore used
as a pre-constrictor in the studies of the relaxation-inducing agonists. Coronary arteries from vitC
deficient guinea pigs were significantly smaller than the controls (p < 0.05, Table 2). Additionally, we
found that for the vitC deficient group, the animal weight was positively correlated with the coronary
artery diameter (p < 0.002, Table 3 and Figure 3a).
Table 2. Artery segment properties, diameter (µm), potassium tension (Nm−1), agonist induced
contraction (% of potassium contraction). Data are expressed as means ± SEM, N is number of animals,
n is number of artery segments, NC = not calculated. * Different from controls, p < 0.05, unpaired t-test.
N, n Controls N, n VitC Deficient
Diameter 16, 35 366 ± 16 16, 35 312 ± 12 *
Potassium, tension 16, 35 3.2 ± 0.2 16, 35 3.1 ± 0.3
Endothelin-1 12, 17
Emax 116 ± 16
12, 17
Emax 108 ± 8
pEC50 8.2 ± 0.1 pEC50 8.3 ± 0.1
Sarafotoxin 6c 8, 20
Emax NC
8, 20
Emax 3 ± 1.6
pEC50 NC pEC50 8.5 ± 0.7
U46619 16, 35
Emax 58 ± 9
16, 35
Emax 64 ± 13
pEC50 6.6 ± 0.1 pEC50 6.7 ± 0.2
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Table 3. Correlation analyses of specific outcomes in the control and vitC deficient groups. Pearson
correlation analyses, N is number of animals, n is number of artery segments, r is Pearson correlation
coefficient, ** p <0.002, *** p < 0.001.
Controls VitC Deficient
N, n Pearson r p Values N, n Pearson r p Values
Diameter vs. weight 16, 35 0.182 0.500 16, 35 0.729 0.001 **
Diameter vs. carb induced dilatation 16, 35 0.010 0.954 16, 35 0.555 0.0005 ***
Diameter vs. carb induced contraction 16, 35 −0.174 0.518 16, 35 −0.286 0.284
BH4 vs. carb induced dilatation 8, 15 0.403 0.105 8, 15 0.057 0.840
BH4 vs. carb induced contraction 8, 15 −0.372 0.172 8, 15 0.232 0.406Nutrients 2017, 9, 691 6 of 14 
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3.3. Vascular Responses to Carbachol
Cumulative concentrations of carb chol in the range of 1 nM to 1 µM markedly relax co onary
artery segments pre-contracted with 40 mM potassium (Figure 4a) and higher conc ntr tions (1 µM to
0.3 mM) c used a rise in the isometric tension in a conc ntration-dependent fashion. Carbachol-induc d
relaxation and sensitivity was not significantly different in coro ary arteries from v tC defic ent gui ea
pigs compared to controls (Fi re 3 ); however, a significa tly positive correlation b tween coronary
artery diamet r and carbachol-induced relaxation was found in coronary arteries from vitC deficie t
guinea pigs, but not in controls (p < 0.001), Table 3 and Figure 3b). The maximal carbachol-induced
contraction response w s significantly lower in segment from vitC deficient compared to controls
(p < 0.001; Figure 4a) and in both vitC deficient and control animals the contractions were independent
on coronary artery diameter (p > 0.05, Table 3). The muscarinic receptor antagonist, atropine
(10 µM), blocked b th the carbachol-induced vasodilation and vasoconst iction from both diet groups
(Figure 2b). To evaluate the contribution of NO and prostan ids to carbachol-induced vasodilation
and vasoconstriction, carbachol concentration- response curves were rec rded during pre-contrac
induced by pota sium and in the presence of the COX i hibitor, indome hacin (10 µM), NOS inhibitor,
L-NAME (100 µM) or in the presence of both indomethacin (10 µM) and L-NAME (100 µM). The
presences f in ibitors alone or i combination revealed no diffe nces in the vasodilator responses
in control compared with vitC d ficient animals, and the augmented vasoconstrictor responses n
arteries from control animals compared to segments fr m vitC defic ent animals were maintained in
the presence of the inhibit rs (Figur 4b–d).
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L-NAME significantly inhibited the vasodilatory response to carbachol in segments from both
control and vitC deficient guinea pigs (p < 0.001; Figure 5a,b); however L-NAME alone had no effect
on the subsequent vasoconstrictor response compared to non-treated segments. In the presence
of indomethacin alone, both carbachol-induced vasodilatation and vasoconstriction were restored
(Figure 5c,d) in arteries from both groups compared to non-treated segments.
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Figure 5. Log-concentration-response curves of coronary artery segments after treatment with L-NAME
and/or indomethacin. The figures illustrate how the combination of inhibitors in artery segments from
the same animal modulates the carbachol-induced vasodilator and constrictor responses. Vasomotor
responses to carbachol in artery segments pre-constricted with 40 mM extracellular potassium: in
absence versus presence of L-NAME in (a) control guinea pigs; (b) vitC deficient. In absence versus
presence of indomethacin in (c) control; and (d) vitC deficient, in absence of L-NAME versus presence
both L-NAME and indomethacin in (e) control guinea pigs; (f) VitC deficient, and in absence of
indomethacin versus presence both L-NAME and indomethacin in (g) control guinea pigs; (h) VitC
deficient. Means ± SEM (n = 8–16), * p < 0.05, ** p < 0.01, *** p < 0.001.
In the presence of L-NAME, indomethacin amplified the carbachol-induce vasoconstriction only
in segments from vitC deficient guinea pi s, suggesting a potential effect arachidonic cid metabolites
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e.g., vasodilator prostanoids counteracting the vasoconstrictor effect of carbachol in coronary arteries
from vitC deficient guinea pigs or increased production of vasoconstrictor leukotrienes, which is
unmasked in the presence of indomethacine. This effect was not recorded for control animals.
In summary, we found that carbachol-induced vasodilator and constrictor responses were
mediated by muscarinic receptors. In vitC deficient guinea pigs, the diameter of the coronary
arteries were significantly and positively correlated with the weight of the animals and the
endothelium-dependent vasorelaxation. These correlations were not present in the control group. In
vitC deficient guinea pigs the muscarinic receptor-induced vasoconstrictor responses were significantly
attenuated compared to controls and partly restored by COX-inhibition.
3.4. Relaxing Responses to SNP
To evaluate the endothelium-independent response to NO, relaxing response to the NO donor
SNP (1 nM to 30 µM) was measured in potassium pre-contracted arteries. SNP induced a concentration
dependent relaxation and the maximal relaxation and the sensitivity to SNP were not affected by the
vitC status in the animals (Figure 4f).
4. Discussion
The present study shows that vasoconstrictor responses to carbachol are significantly decreased
in arteries from vitC deficient guinea pigs as compared to arteries from control animals, proposing a
link between vitC deficiency and compromised vascular function in vivo. Interestingly, contractions
induced by other constrictors: potassium, S6c, U46619 and ET-1 were not affected by vitC status,
suggesting that the contractile apparatus per se is not affected. Although vitC deficiency decreased
plasma BH4 levels, there was no significantly decreased vasodilator capacity compared to controls.
However, vitC deficient guinea pigs had significantly smaller coronary artery diameters than controls,
and in vitC deficient guinea pigs, the decreased diameter correlated with decreased carbachol-induced
vasodilatation. Consequently, it appears that impaired vitC status affects the diameter of the
coronary arteries and the endothelial function; furthermore vitC status induces a specific effect on the
parasympathetic muscarinic receptor system, as measured by attenuated vasoconstrictor responses.
The parasympathetic neurotransmitter, acetylcholine and its analogue carbachol are widely used
to study endothelial dependent/independent vasodilation and vasoconstriction, and the agonist
is relevant since guinea pigs have an extensive network of cholinergic perivascular nerve fibres in
the coronary artery tree [22]. In isolated coronary artery segments, carbachol induced a biphasic
concentration-response pattern with an initial vasodilator response at low concentrations (from
10 nM to 1 µM) followed by a vasoconstrictor response at higher concentrations (from 1 µM to
0.3 mM). Carbachol-responses in the presence of atropine, indomethacin and/or L-NAME in the
organ bath were assessed, revealing that atropine blocked both the carbachol-induced vasodilatation
and vasoconstriction over the entire carbachol concentration interval. This suggests that carbachol
elicits its effect via muscarinic receptors on guinea pig coronary arteries. This is consistent with
previous studies showing that acetylcholine-induced vasodilator responses in bovine [25], simian [26]
and mice [27] coronary arteries are mediated predominantly by endothelial muscarinic M3 receptors,
and that acetylcholine induced vasoconstrictor responses are mediated by vascular M3 receptors in
bovine [28,29] and porcine [30,31] coronary arteries.
In this study, we found that in vitC deficient guinea pigs, the endothelial-dependent vasodilation
was significantly correlated with coronary artery diameter; a correlation that was not present in
controls. Furthermore, we found coronary artery diameters were significantly smaller in vitC deficient
guinea pigs as compared to control guinea pigs, despite sampling at uniform, anatomically defined,
orientation. These results suggest that vitC deficiency potentially impair coronary artery growth and
endothelial function of young guinea pigs. Hence, those guinea pigs that responded most sensitively
to vitC restriction further developed more overall growth retardation with consequently impaired
coronary artery growth and endothelial function. In the control group, in contrast, the variation in
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artery diameter did not reflect a pathophysiological response, but rather, a random variation in growth.
Previously, degenerative changes in the capillary endothelium have been found in scorbutic guinea pigs
whereas the larger arteries showed no abnormalities [32]. However, although we found this correlation
between artery diameter and endothelial function in vitC deficient animals and not in controls;
we found no overall effect of vitC deficiency when comparing the two groups. Treatment of the
coronary artery segments with L-NAME abolished the initial carbachol-induced vasodilator response
in both diet groups. In contrast, indomethacin did not significantly affect the vasodilator response
between groups, suggesting that carbachol-induced vasodilator response was predominantly driven by
endothelial-dependent NO release. Importantly, the vasodilator responses were investigated in arteries
preconstricted with high extracellular concentration of potassium. High potassium concentrations
depolarize VSMC and endothelial cells [33] which consequently hide a putative endothelium-derived
hyperpolarizing factor (EDHF) mediated vasodilator effect [34]. Therefore, blocking the contribution
of EDHF to vasodilation allowed the isolation of the effects of NO and prostaglandins on carbachol
induced vasodilation.
Muscarinic receptors are widely expressed in smooth muscle cells in several organs,
and diet-induced ascorbate deficiency in guinea pigs has previously been shown to reduce
muscarinic-cholinergic receptor density [21]. Increased oxidative stress has been found to
acutely reduce muscarinic receptor-mediated smooth muscle cell constriction in guinea pigs [19],
and increased ROS production in ischemia/reperfusion reduce efficacy and sensitivity to
cholinergic stimulation [35,36], linking redox imbalance to functional consequences mediated via
muscarinic receptors.
Stimulating the arteries with the NO donor sodium nitroprussid revealed vasodilation with
similar sensitivity and maximal effect in arteries from vitC deficient and control guinea pigs (Figure 4f).
NO mediates a vasodilator effect by binding to soluble guanylyl cyclase (sGC) in VSMC. Guanylyl
then catalyses the production of cGMP, which activates protein kinase G that via dephosphorylation of
myosin light chain leads to vasorelaxation [37]. Oxidative stress has been showed to down-regulate
soluble guanylyl cyclase expression and activity [38]. In present study, we found no effect of vitC
deficiency on the NO-mediated vasodilation, indicating that the sGC activity was unaltered by the
vitC status.
When coronary artery segments were treated with L-NAME and/or indomethacin, the
carbachol-induced vasoconstrictor response remained reduced in arteries from vitC deficient compared
to control animals. However, indomethacin increased the carbachol-induced vasoconstrictor response
in eNOS blocked segments from vitC deficient animals, which was not present in arteries from control
animals. This suggests that vitC deficiency promotes the release of vasodilator prostanoids in coronary
arteries when stimulated with carbachol. Vasodilator prostanoids have previously been found to
negate the effect of coronary vasoconstrictors after myocardial infarction [39], a condition known to
induce oxidative stress [40] and be detrimental to cellular function and survival. In contrast, inhibition
of prostanoid production has been found to have little effect in healthy humans [41] and dogs [42].
In this study, prostanoid-induced suppression of carbachol vasoconstrictor responses in coronary
arteries were increased in vitC deficient guinea pigs, suggesting a compensatory role in the regulation
of coronary vascular tone under vitC and BH4 deficiency. The contractile responses induced by either
extracellular potassium, U46619, S6c or ET-1 were not affected by vitC status, supporting the idea that
the general vasoconstrictor capacity is not affected by vitC deficiency.
VitC deficiency (defined as plasma concentrations <23 µM) is surprisingly common, affecting
~15% of adults in the Western World with even higher prevalence among individuals who smoke, have
high BMI, low socioeconomic status [7] as well as children with underlying medical conditions [43,44].
Epidemiological studies have shown an association between vitC deficiency and an increased risk
of cardiovascular disease; however, the mechanistic link has not been elucidated [45,46]. Altered
vasomotion and reactivity of coronary arteries plays an important role in pathophysiologic mechanisms
involved in heart disease. The parasympathetic nervous system is known to provide a modulating
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influence on the response of coronary arteries to local metabolic requirements in the heart [47].
Moreover, muscarinic receptors are known to be expressed in human coronary arteries [48]. Patients
with variant angina or coronary stenosis have been found to have altered coronary vasoconstriction
after injection of acetylcholine, pointing toward a causal relationship with altered muscarinic receptor
response and disease [49,50]. The observation that muscarinic receptor mediated contraction is
impaired as a result of vitC deficiency is of potential importance, not only in regulation of coronary
artery vasomotion, but also in other tissues that are highly dependent on parasympathetic-muscarinic
receptor-mediated contraction (bladder, esophagus, intestines, pancreas, and salivary glands). For
obvious ethical reasons, it is impossible to perform long-term controlled trials on humans to establish
the consequence of vitC deficiency on vasculature and present knowledge is therefore restricted
to indirect evidence. Applying the guinea pig as a unique and validated model of diet-induced
vitC deficiency, this study shows that chronic vitC deficiency in vivo alters the response of the
coronary arteries to parasympathetic stimuli. This provides a link between vitC deficiency and
cardiovascular disease, proposing a yet undisclosed, specific, effect of vitC in the modulation
of muscarinic receptor-modulated response within the vascular wall. Though requiring further
investigation, the apparent association between vitC status and coronary artery contraction may prove
relevant in the prevention and treatment of cardiovascular diseases in humans with poor vitC status.
The present study has several limitations. Based on existing literature, we expected that
vitC deficiency reduced NO-mediated vasodilation as a consequence of the decreased BH4 plasma
concentration. The potential reason for the lack of correlation between the BH4 plasma concentrations
and endothelial function could be that we determined biopterines and vitC in the plasma, rather than
in the arteries, which could potentially more adequately have reflected the vessel status. Interestingly,
a correlation between animal weight, artery diameter and endothelial function in vitC deficient guinea
pigs was found. Future studies are needed to elaborate on a causal relationship and putative functional
consequences e.g., clarifying if vitC deficiency induces morphological changes of the heart muscle
and vessels. Furthermore, measurements of intracellular calcium concentrations would be highly
relevant to determine if vitC deficiency alters cytosolic calcium levels and handling, which can lead
to increased tone and decreased vessel diameter. Here, the effect of vitC deficiency was evaluated
in young guinea pigs—reproductive maturity is reached at around 10 weeks of age—with no other
underlying pathophysiological condition. We found that the coronary arteries were highly resistant to
mechanically endothelial denudation, suggesting that the animals, despite vitC deficiency, retained a
high NO capacity and/or sensitivity in the coronary arteries. However, it could be speculated that in the
presence of an additional vascular disease, such as atherosclerosis, left ventricular hypertension [51] or
even age-related reductions in compensatory abilities, a decreased vitC concentration and consequently,
a reduced capacity to recycle BH4, may be crucial in preserving an adequate vasodilator capacity [52].
Our finding, that the muscarinic receptor system is highly sensitive to vitC deficiency, is a novel
and so far unrecognized effect of in vivo vitC deficiency. Future studies are needed to elucidate the
mechanisms underlying the impaired muscarinic receptor mediated contraction observed here and to
study other tissues with highly dependent parasympathetic-muscarinic receptor-mediated contraction
(e.g., bladder, esophagus, intestines, pancreas, and salivary glands).
5. Conclusions
The present study shows that chronic vitC deficiency impairs vasomotor function of coronary
arteries. During vitC deficiency, the endothelial function is reduced, with decreasing vessel diameter
and carbachol-induced vasoconstrictor responses being significantly impaired. The carbachol-induced
effects are apparently mediated by altered muscarinic receptor activity. Although further studies
are required to evaluate the underlying mechanisms and the potential clinical implications, these
findings may provide a link between chronic vitC deficiency and increased risk of cardiovascular
disease reported in numerous epidemiological studies.
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